| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.20.1.259 |
| P698 | PubMed publication ID | 10634827 |
| P50 | author | Per Morten Sandset | Q38544475 |
| P2093 | author name string | Hansen JB | |
| Nordoy A | |||
| Bonaa KH | |||
| Nilsen H | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | simvastatin | Q670131 |
| P304 | page(s) | 259-265 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. | |
| P478 | volume | 20 |
| Q28219488 | A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels |
| Q36344861 | Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism |
| Q80547504 | Age associated alterations in costimulatory and adhesion molecule expression in lupus-prone mice are attenuated by food restriction with n-6 and n-3 fatty acids |
| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q44518845 | Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia |
| Q44213795 | Boron supplementation and activated factor VII in healthy men. |
| Q34011154 | Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care |
| Q34042886 | Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia |
| Q34106488 | Effects of HMG-CoA reductase inhibitor on hemostasis |
| Q35200997 | Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes |
| Q48181231 | Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. |
| Q36957089 | Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules |
| Q34530720 | Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? |
| Q82220769 | Free fatty acids and stroke from atrial fibrillation |
| Q38164650 | Icosapent ethyl for treatment of elevated triglyceride levels |
| Q46663873 | Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction |
| Q34287966 | Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review |
| Q37507934 | Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia |
| Q38557891 | Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. |
| Q46497280 | Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity |
| Q35629424 | Significant inverse association of marine n-3 fatty acids with plasma fibrinogen levels in Japanese in Japan but not in whites or Japanese Americans. |
| Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
| Q37276466 | Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? |
| Q90206447 | The Physiological Effect of n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Intake and Exercise on Hemorheology, Microvascular Function, and Physical Performance in Health and Cardiovascular Diseases; Is There an Interaction of Exercise and Dietary n-3 |
| Q37752429 | The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective |
| Q34285956 | Therapeutic considerations for postprandial dyslipidaemia |
| Q34418028 | Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease. |
| Q45141853 | Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state |
Search more.